Xingmei Zhang
Company: Hansa Biopharma
Job title: Franchise Program Lead
Seminars:
IgG Cleaving Enzymes as a Potential Solution to the NAb Challenge 11:45 am
An overview of IgG cleaving enzymes: their MOA and translatability for use in conjunction with gene therapies Discussing clinical data from non-gene therapy indications Considerations for treatment timing and dosing of gene therapy post-administration of enzymeRead more
day: Day 2 CLINICAL AM